Technical Analysis for ADXS - Advaxis Inc

Grade Last Price % Change Price Change
F 1.2500 -2.72% -0.0350
ADXS closed down 2.72 percent on Friday, March 31, 2023, on 1.16 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.72%
Narrow Range Bar Range Contraction -2.72%
Inside Day Range Contraction -2.72%
Wide Bands Range Expansion -2.72%
Oversold Stochastic Weakness -2.72%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Advaxis Inc Description

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Prostate Cancer Immunotherapy Immunotherapies Non Small Cell Lung Cancer Prostvac Treatment Of Non Small Cell Lung Cancer Treatment Of Prostate Cancer Seagen

Is ADXS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.5
52 Week Low 0.055
Average Volume 7,185
200-Day Moving Average 2.3971
50-Day Moving Average 1.7325
20-Day Moving Average 1.4943
10-Day Moving Average 1.3255
Average True Range 0.1705
RSI 39.39
ADX 28.63
+DI 19.3780
-DI 27.4469
Chandelier Exit (Long, 3 ATRs) 1.3885
Chandelier Exit (Short, 3 ATRs) 1.7115
Upper Bollinger Bands 1.8849
Lower Bollinger Band 1.1037
Percent B (%b) 0.19
BandWidth 52.2787
MACD Line -0.1151
MACD Signal Line -0.1007
MACD Histogram -0.0144
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.4750
Resistance 3 (R3) 1.5000 1.4500 1.4375
Resistance 2 (R2) 1.4500 1.3927 1.4375 1.4250
Resistance 1 (R1) 1.3500 1.3573 1.3250 1.3250 1.4125
Pivot Point 1.3000 1.3000 1.2875 1.2875 1.3000
Support 1 (S1) 1.2000 1.2427 1.1750 1.1750 1.0875
Support 2 (S2) 1.1500 1.2073 1.1375 1.0750
Support 3 (S3) 1.0500 1.1500 1.0625
Support 4 (S4) 1.0250